Stomatology ›› 2025, Vol. 45 ›› Issue (7): 511-517.doi: 10.13591/j.cnki.kqyx.2025.07.006

• Basic and Clinical Research • Previous Articles     Next Articles

A novel ROS-responsive nanocarrier for antioxidant therapy in endodontic inflammation

WANG Mingxin, DUAN Yiyuan, FENG Kejia, NIE Chenyu, MA Qian()   

  1. Department of General Dentistry, The Affiliated Stomatological Hospital of Nanjing Medical University; State Key Laboratory Cultivation Base of Research, Prevention and Treatment for Oral Diseases; Jiangsu Province Engineering Research Center of Stomatological Translational Medicine, Nanjing 210029, China
  • Received:2025-02-08 Online:2025-07-28 Published:2025-07-24

Abstract:

Objective To explore the effects of cerium-doped mesoporous bioactive glass nanoparticles (Ce-MBGNs) as reactive oxygen species (ROS)-responsive nanocarriers on inflammation in pulp and their potential to promote odontogenic differentiation of dental pulp stem cells (DPSCs). Methods The cytotoxicity of Ce-MBGNs was assessed by CCK-8. The expression of mRNA of osteogenic/odontogenic differentiation in DPSCs and that of inflammatory factor in RAW264.7 cells were detected by RT-qPCR. Alkaline phosphatase and Alizarin Red S staining were utilized to investigate their ability to promote dentin mineralization. The ability of Ce-MBGNs to scavenge ROS was evaluated by immunofluorescence and JC-1 staining was used to assess the membrane potential (MMP) of mitochondrial. Results Ce-MBGNs exhibited good biocompatibility and significantly increased the expression of osteogenic/odontogenic-related genes in DPSCs, promoting mineralization. Additionally, Ce-MBGNs effectively scavenged intracellular ROS, maintained MMP, inhibited the expression of pro-inflammatory factors, and promoted the expression of anti-inflammatory factors. Conclusion Ce-MBGNs can protect DPSCs from oxidative damage by maintaining the MMP of mitochondrial and controlling inflammation, and promote their odontoblastic differentiation, providing a theoretical basis for the development of novel therapeutic agents for oral treatment.

Key words: Ce-MBGNs, dental pulp stem cells, immunomodulation, osteogenic/odontoblastic differentiation

CLC Number: